Not Tagged
Not Tagged
['lung', 'improve']
later this morning, we will share late-breaking research from w/ highlighting a new combination therapy that improves survival for patients with immunotherapy-resistant, non-small cell lung cancer. #asco2022 
Cedars-Sinai is home to some of the most advanced biomedical research and training programs in the world. Follow @cedarssinai for more.